Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.960
-0.010 (-0.51%)
At close: Nov 13, 2026, 4:00 PM EST
1.960
0.00 (0.00%)
After-hours: Nov 13, 2026, 5:29 PM EST
Pacific Biosciences of California Employees
Pacific Biosciences of California had 485 employees as of December 31, 2025. The number of employees decreased by 90 or 15.65% compared to the previous year. That makes Pacific Biosciences of California the 20,342nd largest employer in the world and 2,708th in the United States.
Employees
485
Change (1Y)
-90
Growth (1Y)
-15.65%
Revenue / Employee
$332,771
Profits / Employee
-$270,584
Market Cap
613.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 485 | -90 | -15.65% |
| Dec 31, 2024 | 575 | -221 | -27.76% |
| Dec 31, 2023 | 796 | 27 | 3.51% |
| Dec 31, 2022 | 769 | 41 | 5.63% |
| Dec 31, 2021 | 728 | 316 | 76.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| QuidelOrtho | 6,500 |
| Varex Imaging | 2,500 |
| Tactile Systems Technology | 1,086 |
| Cytek Biosciences | 703 |
| InMode | 660 |
| AVITA Medical | 226 |
| Sight Sciences | 186 |
| Anteris Technologies Global | 174 |
PACB News
- 4 days ago - PacBio price target lowered to $2.70 from $3.05 at UBS - TheFly
- 8 days ago - PacBio price target raised to $3 from $2 at Piper Sandler - TheFly
- 8 days ago - PacBio price target raised to $2 from $1.25 at Barclays - TheFly
- 9 days ago - PacBio narrows FY26 revenue view to $155M-$160M from $155M-$165M - TheFly
- 9 days ago - PacBio reports Q3 EPS (11c), consensus (13c) - TheFly
- 9 days ago - Pacific Biosciences of California Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Pacific Biosciences of California Earnings release: Q3 2026 - Filings
- 9 days ago - Pacific Biosciences of California Quarterly report: Q3 2026 - Filings